HomeComparePODD vs IBM

PODD vs IBM: Dividend Comparison 2026

PODD yields 0.96% · IBM yields 2.83%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IBM wins by $6.7K in total portfolio value
10 years
PODD
PODD
● Live price
0.96%
Share price
$208.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$102.34
Full PODD calculator →
IBM
International Business Machines
● Live price
2.83%
Share price
$237.25
Annual div
$6.72
5Y div CAGR
3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.7K
Annual income
$463.53
Full IBM calculator →

Portfolio growth — PODD vs IBM

📍 IBM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPODDIBM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PODD + IBM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PODD pays
IBM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PODD
Annual income on $10K today (after 15% tax)
$81.73/yr
After 10yr DRIP, annual income (after tax)
$86.99/yr
IBM
Annual income on $10K today (after 15% tax)
$240.76/yr
After 10yr DRIP, annual income (after tax)
$394.00/yr
At 15% tax rate, IBM beats the other by $307.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PODD + IBM for your $10,000?

PODD: 50%IBM: 50%
100% IBM50/50100% PODD
Portfolio after 10yr
$24.4K
Annual income
$282.93/yr
Blended yield
1.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PODD right now

PODD
Analyst Ratings
36
Buy
10
Hold
3
Sell
Consensus: Buy
Price Target
$357.25
+71.7% upside vs current
Range: $286.00 — $435.00
Altman Z
7.1
Piotroski
7/9
IBM
Analyst Ratings
1
Strong
20
Buy
24
Hold
4
Sell
Consensus: Hold
Price Target
$349.50
+47.3% upside vs current
Range: $304.00 — $380.00
Altman Z
3.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PODD buys
0
IBM buys
0
No recent congressional trades found for PODD or IBM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPODDIBM
Forward yield0.96%2.83%
Annual dividend / share$2.00$6.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%3%
Portfolio after 10y$21.0K$27.7K
Annual income after 10y$102.34$463.53
Total dividends collected$995.00$3.7K
Payment frequencyquarterlyquarterly
SectorStockTechnology
Analyst consensusBuyHold
Analyst price target$357.25$349.50

Year-by-year: PODD vs IBM ($10,000, DRIP)

YearPODD PortfolioPODD Income/yrIBM PortfolioIBM Income/yrGap
1← crossover$10,796$96.15$11,132$291.74$336.00IBM
2$11,649$97.01$12,375$308.58$726.00IBM
3$12,562$97.83$13,741$325.97$1.2KIBM
4$13,540$98.60$15,239$343.91$1.7KIBM
5$14,587$99.32$16,882$362.40$2.3KIBM
6$15,708$100.00$18,681$381.46$3.0KIBM
7$16,909$100.64$20,651$401.10$3.7KIBM
8$18,193$101.24$22,807$421.31$4.6KIBM
9$19,569$101.81$25,165$442.12$5.6KIBM
10$21,041$102.34$27,743$463.53$6.7KIBM

PODD vs IBM: Complete Analysis 2026

PODDStock

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Full PODD Calculator →

IBMTechnology

International Business Machines Corporation provides integrated solutions and services worldwide. The company operates through four business segments: Software, Consulting, Infrastructure, and Financing. The Software segment offers hybrid cloud platform and software solutions, such as Red Hat, an enterprise open-source solutions; software for business automation, AIOps and management, integration, and application servers; data and artificial intelligence solutions; and security software and services for threat, data, and identity. This segment also provides transaction processing software that supports clients' mission-critical and on-premise workloads in banking, airlines, and retail industries. The Consulting segment offers business transformation services, including strategy, business process design and operations, data and analytics, and system integration services; technology consulting services; and application and cloud platform services. The Infrastructure segment provides on-premises and cloud-based server and storage solutions for its clients' mission-critical and regulated workloads; and support services and solutions for hybrid cloud infrastructure, as well as remanufacturing and remarketing services for used equipment. The Financing segment offers lease, installment payment, loan financing, and short-term working capital financing services. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.

Full IBM Calculator →
📬

Get this PODD vs IBM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PODD vs SCHDPODD vs JEPIPODD vs OPODD vs KOPODD vs MAINPODD vs MSFTPODD vs CSCOPODD vs HPQ

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.